Trade CVRx, Inc. - CVRX CFD

Trading Conditions

• Type: CFD
• Spread: 0.08
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 8.65
• Open: 8.54
• 1-Year Change: -31.52%
• Day's Range: 8.34 - 8.8

What is CVRx, Inc. (CVRX)?

CVRx, Inc. is a medical device company specializing in the development and commercialization of neuromodulation therapies for the treatment of cardiovascular diseases. The company focuses on technologies that modulate the autonomic nervous system to address conditions such as hypertension and heart failure. CVRx's products involve implantable devices designed to regulate nerve activity and improve cardiovascular function. The company engages in research, clinical development, and regulatory activities to advance its therapeutic offerings. CVRx operates within the medical technology sector, contributing to innovative treatment options for patients with chronic cardiovascular conditions. Its approach integrates engineering, clinical science, and medical expertise.

CVRx, Inc. Stock Price Today: Live Overview

The price today is shaped by ongoing trading, as CVRx, Inc. holds a price of $8.47. It has ranged from $8.22 to $8.8 today, with a daily change percentage of -3.0093%.

FAQ: CVRx, Inc. (CVRX)

What is the current price of CVRX stock?

The current price is $8.47.

Does CVRX pay dividends?

Dividends are not paid by the company.

Does CVRX have a formal corporate presence or regional headquarters in the UAE?

CVRx, Inc. operates through partners and distributors and does not have an official office or subsidiary in the UAE.

What is CVRX best known for?

The company is most famous for its implantable neuromodulation devices for hypertension.

What assets are typically shown together with CVRX?

Commonly shown alongside CVRX: Reliance Worldwide Corporation, ARK Space Exploration & Innovation ETF, Collegium Pharmaceutical Inc